Patients with asthma were excluded from tiotropium clinical trials, so its efficacy in this population is unknown. To use the HandiHaler, patients place a tiotropium capsule into the device ...

Boehringer’s lung drug Spiriva, approved for chronic obstructive pulmonary disease (COPD) and asthma, generated net sales of 2.4 billion euros, down 11.4% compared with last year, which the ...

With the earlier definition of chronic obstructive pulmonary disease (COPD), patients were essentially defined as having either chronic bronchitis or emphysema, with emphysema classified as a ...

As the EU patent expires on its flagship respiratory diseases product, Spiriva, Boehringer Ingelheim is looking to newer diabetes and respiratory drugs under the leadership of a new CEO.